×
About 75,943 results

ALLMedicine™ Multiple Sclerosis Center

Research & Reviews  23,388 results

Long-term outcome after COVID-19 infection in multiple sclerosis: a nation-wide multice...
https://doi.org/10.1111/ene.15477
European Journal of Neurology; Bsteh G, Assar H et. al.

Jun 26th, 2022 - Long-term outcome after COVID-19 in patients with multiple sclerosis (pwMS) is scarcely studied and controlled data are lacking. To compare long-term outcome after COVID-19 in pwMS to a matched control group of pwMS without COVID-19. We included p...

Effects of Different Exercise Therapies on Balance Function and Functional Walking Abil...
https://doi.org/10.3390/ijerph19127175
International Journal of Environmental Research and Publi... Hao Z, Zhang X et. al.

Jun 25th, 2022 - The objective of this research is to assess the effects of seven different exercise therapies (aquatic exercise, aerobic exercise, yoga, Pilates, virtual reality exercise, whole-body vibration exercise, and resistance exercise) on the balance func...

Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Anima...
https://doi.org/10.4049/jimmunol.2100176
Journal of Immunology (Baltimore, Md. : 1950); Kiapour N, Wu B et. al.

Jun 25th, 2022 - The objective of this study is to determine the mechanism of action of anti-CD52 mAb treatment in patients with relapsing-remitting multiple sclerosis (RRMS). Experimental autoimmune encephalomyelitis (EAE), an animal model of the disease, was use...

Reparative inflammation in multiple sclerosis.
https://doi.org/10.1016/j.smim.2022.101630
Seminars in Immunology; Cantuti-Castelvetri L, Gokce O et. al.

Jun 25th, 2022 - Reparative inflammation in multiple sclerosis.|2022|Cantuti-Castelvetri L,Gokce O,Simons M,|

Blood levels of brain-derived neurotrophic factor (BDNF) in people with multiple sclero...
https://doi.org/10.1016/j.msard.2022.103984
Multiple Sclerosis and Related Disorders; Karimi N, Ashourizadeh H et. al.

Jun 25th, 2022 - Multiple sclerosis is an autoimmune demyelinating disease marked by the involvement of multiple pathophysiological pathways, including BDNF. BDNF (brain-derived neurotrophic factor) is one of the main neurotrophic factors in the adult brain. The a...

see more →

Guidelines  16 results

Supporting the Role of Parenting for People with Multiple Sclerosis: A Guide for Clinic...
https://doi.org/10.1016/j.apmr.2022.05.010
Archives of Physical Medicine and Rehabilitation; Rider JV, Selim J

Jun 18th, 2022 - Supporting the Role of Parenting for People with Multiple Sclerosis: A Guide for Clinicians.|2022|Rider JV,Selim J,|

Vision Problems in Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.08.003
Archives of Physical Medicine and Rehabilitation; Costa SL, Pandey K et. al.

Sep 29th, 2020 - Vision Problems in Multiple Sclerosis.|2020|Costa SL,Pandey K,Hrdina J,Rondon M,Devos H,|

Serum neurofilament light as a biomarker in progressive multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538221
Neurology Kapoor R, Smith KE et. al.

Jul 18th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...

Practical Sleep Information for People With Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.03.009
Archives of Physical Medicine and Rehabilitation; Siengsukon C, Karahan AY et. al.

May 14th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|

Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis...
https://doi.org/10.1016/j.msard.2019.04.004
Multiple Sclerosis and Related Disorders; Lebrun C, Vukusic S et. al.

Jun 5th, 2019 - To establish recommendations on immunization for patients with multiple sclerosis (MS) BACKGROUND: Vaccines have been suspected in the past to trigger MS and relapses. With the extension of the immunoactive treatment arsenal, other concerns have b...

see more →

Drugs  389 results see all →

Clinicaltrials.gov  2,551 results

Uveitis/Intraocular Inflammatory Disease Biobank (iBank)
https://clinicaltrials.gov/ct2/show/NCT02656381

Jun 24th, 2022 - Uveitis refers to a large group of intraocular inflammatory diseases that can cause devastating visual loss in adults and children. This study establishes a clinical database and biospecimen repository for the identification of novel factors relev...

Relating Genetic and Environmental Risk Scores to Multiple Sclerosis Susceptibility
https://clinicaltrials.gov/ct2/show/NCT01617395

Jun 24th, 2022 - Objective. The overall objective of this study is to investigate the genetic, immune, and neuroimaging profiles that may increase a person s risk of developing multiple sclerosis (MS) in order to identify and validate predictive biomarkers in popu...

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
https://clinicaltrials.gov/ct2/show/NCT02784210

Jun 24th, 2022 - Objectives. The primary aim of this pilot study is to assess the effects of short-term, high-dose corticosteroid administration on the 12-week evolution of multiple sclerosis lesions with centripetal enhancement pattern on magnetic resonance imagi...

Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
https://clinicaltrials.gov/ct2/show/NCT04799288

Jun 24th, 2022 - Study Description: In this single center, single arm, open label, baseline versus treatment pilot clinical trial, sixteen subjects with HAM/TSP will receive teriflunomide 14mg by mouth once a day in an initial 9 month treatment phase, followed by ...

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1
https://clinicaltrials.gov/ct2/show/NCT02634307

Jun 24th, 2022 - The primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 8700 for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS). The secondary objective of this study is to evaluate treatment effect over ti...

see more →

News  3,976 results

Autoimmune disorder drugs top list of meds linked to headache
https://www.mdedge.com/neurology/article/255727/headache-migraine/autoimmune-disorder-drugs-top-list-meds-linked-headache
Randy Dotinga

Jun 23rd, 2022 - DENVER – Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contribute to, ac.

Top Medications Most Often Linked to Headache
https://www.medscape.com/viewarticle/976124

Jun 23rd, 2022 - DENVER, Colorado — Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in a federal side effect database that anyone can contrib...

Novel Drug for Relapsing-Remitting MS: New Phase 2 Data
https://www.medscape.com/viewarticle/976036

Jun 22nd, 2022 - The novel drug vidofludimus calcium (Immunic Therapeutics) is safe and effective for patients with relapsing-remitting multiple sclerosis (RRMS), new research suggests. Vidofludimus calcium is an investigational oral second-generation selective di...

COVID Vaccination in DMT-Treated MS Patients: New Data
https://www.medscape.com/viewarticle/975977

Jun 21st, 2022 - NATIONAL HARBOR, Maryland ― The latest updates on COVID-19 vaccination response among patients with multiple sclerosis (MS) who are treated with disease-modifying therapy (DMT) show that if patients do contract the virus, cases are mild, and serio...

No Clear Answers From MS Drug Discontinuation Trial
https://www.medscape.com/viewarticle/975917

Jun 20th, 2022 - NATIONAL HARBOR, Maryland — The first randomized trial to examine whether older adults with multiple sclerosis (MS) can safely discontinue disease-modifying therapy (DMT) after years of being relapse-free failed to deliver a definitive conclusion....

see more →

Patient Education  57 results see all →